Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. 

NEWS ARTICLES

Coalition to Stop Flu Chairman Former Sen. Tom Daschle Quoted in Endpoints News

National Academy of Medicine: “An effective pandemic preparedness and response system is possible”